BIG PHARMA POLITICS: Consumers pressure politicians to do something about rising drug prices. Read More
It’s not often that Voices for Affordable Health can report that the prices of most prescription drugs in the United States did not rise during the second quarter of this year.
That’s right. Unfortunately, drug prices aren’t dropping either.
An analysis by GoodRx, a company that tracks drug prices from more than 70,000 U.S. pharmacies, found that between April 1 and June 30, 2019, the average list price of both brand and generic drugs remained basically flat – falling by just .34 percent.
There’s no indication what consumers might expect the rest of the year. Doug Hirsch, co-CEO of GoodRx, writes “flat prices are not a solution – they just freeze the problem for a spell.”
The GoodRx report also includes some interesting data about drug pricing and use.
What has your experience been? Have the prices for your prescriptions stabilized? Share your experience with Voices for Affordable Health.